Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MUROMONAB-CD3 vs NABILONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MUROMONAB-CD3 vs NABILONE: Safety Overview

Metric MUROMONAB-CD3 NABILONE
Total FAERS Reports 114 440
Deaths Reported 28 2
Death Rate 24.6% 0.5%
Hospitalizations 28 224
Average Patient Age 30.2 yrs 45.3 yrs
% Female Patients 45.0% 44.4%
FDA Approval Date N/A Dec 26, 1985
Manufacturer N/A Bausch Health US LLC
Route N/A ORAL
Marketing Status N/A Discontinued